Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Generic_Tina Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1511682976639119365.png) Tina Banerjee [@Generic_Tina](/creator/twitter/Generic_Tina) on x XX followers
Created: 2025-06-24 00:35:16 UTC

SK Bioscience initiates global Phase X trial of PCV21 vaccine. IDT Biologika shows revenue growth in 1Q25, on track to meet 2025 guidance. 1Q25 base business revenue increased XX% YoY.

![](https://pbs.twimg.com/card_img/1937308522540417024/GJUdzdBq?format=jpg&name=800x419)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1937308506954301942/c:line.svg)

**Related Topics**
[quarterly earnings](/topic/quarterly-earnings)
[$302440ks](/topic/$302440ks)

[Post Link](https://x.com/Generic_Tina/status/1937308506954301942)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Generic_Tina Avatar Tina Banerjee @Generic_Tina on x XX followers Created: 2025-06-24 00:35:16 UTC

SK Bioscience initiates global Phase X trial of PCV21 vaccine. IDT Biologika shows revenue growth in 1Q25, on track to meet 2025 guidance. 1Q25 base business revenue increased XX% YoY.

XX engagements

Engagements Line Chart

Related Topics quarterly earnings $302440ks

Post Link

post/tweet::1937308506954301942
/post/tweet::1937308506954301942